NOT KNOWN DETAILS ABOUT HEMGENIX

Quantity of eligible individuals: CDEC talked about the uncertainty in the amount of people with reasonably intense to severe hemophilia B in Canada suitable for etranacogene dezaparvovec. Scientific industry experts consulted by CADTH indicated that some people that are categorized as possessing delicate or moderate illness might have a serious bl